Literature DB >> 10887106

NFAT-controlled expression of GFP permits visualization and isolation of antigen-stimulated primary human T cells.

E Hooijberg1, A Q Bakker, J J Ruizendaal, H Spits.   

Abstract

We have developed a new method that allows detection and isolation of viable, antigen-specific, human T cells from a heterogeneous pool of T cells. We have engineered a self-inactivating retroviral vector containing multiple (3 or 6) nuclear factor of activated T-cell (NFAT)-binding sites, followed by the minimal IL2 promoter and the reporter gene GFP. Jurkat cells, primary T-cell blasts, and T-cell clones were transduced with high efficiency (20%-40%). Stimulation of the transduced cells with phorbol myristate acetate (PMA) and ionomycin resulted in a high level expression of GFP that was maximal after 12 to 14 hours and remained stable for another 12 hours. Activation of T cells carrying the construct containing 6 NFAT-binding sites resulted in the highest mean fluorescence intensity. Cyclosporin-A and FK506 were able to block the activation-dependent GFP expression. Activation of transduced T-cell blasts with the superantigen staphylococcal enterotoxin B or of transduced antigen-specific T-cell clones with cognate antigen resulted in GFP expression. After an overnight stimulation of a heterogeneous T-cell bulk culture with an HLA mismatched stimulator cell (JY), the GFP expressing cells were cloned. As expected, the cloning frequency of the antigen-specific GFP(+) cells was considerably higher than that of the total T-cell population. Most of the T-cell clones were either cytolytic, or proliferative toward JY stimulator cells. Interestingly, we also isolated T-cell clones that were noncytolytic and nonproliferative toward JY cells, but specifically up-regulated GFP after an overnight stimulation with JY. (Blood. 2000;96:459-466)

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10887106

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  27 in total

1.  Concurrent visualization of trafficking, expansion, and activation of T lymphocytes and T-cell precursors in vivo.

Authors:  Il-Kang Na; John C Markley; Jennifer J Tsai; Nury L Yim; Bradley J Beattie; Alexander D Klose; Amanda M Holland; Arnab Ghosh; Uttam K Rao; Matthias T Stephan; Inna Serganova; Elmer B Santos; Renier J Brentjens; Ronald G Blasberg; Michel Sadelain; Marcel R M van den Brink
Journal:  Blood       Date:  2010-05-28       Impact factor: 22.113

2.  Functional TCR T cell screening using single-cell droplet microfluidics.

Authors:  Aude I Segaliny; Guideng Li; Lingshun Kong; Ci Ren; Xiaoming Chen; Jessica K Wang; David Baltimore; Guikai Wu; Weian Zhao
Journal:  Lab Chip       Date:  2018-12-04       Impact factor: 6.799

3.  Improving adoptive T cell therapy by targeting and controlling IL-12 expression to the tumor environment.

Authors:  Ling Zhang; Sid P Kerkar; Zhiya Yu; Zhili Zheng; Shicheng Yang; Nicholas P Restifo; Steven A Rosenberg; Richard A Morgan
Journal:  Mol Ther       Date:  2011-02-01       Impact factor: 11.454

4.  Changing T cell specificity by retroviral T cell receptor display.

Authors:  H W Kessels; M D van Den Boom; H Spits; E Hooijberg; T N Schumacher
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

5.  Imaging TCR-dependent NFAT-mediated T-cell activation with positron emission tomography in vivo.

Authors:  V Ponomarev; M Doubrovin; C Lyddane; T Beresten; J Balatoni; W Bornman; R Finn; T Akhurst; S Larson; R Blasberg; M Sadelain; J G Tjuvajev
Journal:  Neoplasia       Date:  2001 Nov-Dec       Impact factor: 5.715

6.  Tumor Antigen and Receptor Densities Regulate Efficacy of a Chimeric Antigen Receptor Targeting Anaplastic Lymphoma Kinase.

Authors:  Alec J Walker; Robbie G Majzner; Ling Zhang; Kelsey Wanhainen; Adrienne H Long; Sang M Nguyen; Paola Lopomo; Marc Vigny; Terry J Fry; Rimas J Orentas; Crystal L Mackall
Journal:  Mol Ther       Date:  2017-07-01       Impact factor: 11.454

7.  Evaluation of γ-retroviral vectors that mediate the inducible expression of IL-12 for clinical application.

Authors:  Ling Zhang; Steven A Feldman; Zhili Zheng; Nachimuthu Chinnasamy; Hui Xu; Azam V Nahvi; Mark E Dudley; Steven A Rosenberg; Richard A Morgan
Journal:  J Immunother       Date:  2012-06       Impact factor: 4.456

8.  Low ligand requirement for deletion and lack of synapses in positive selection enforce the gauntlet of thymic T cell maturation.

Authors:  Peter J R Ebert; Lauren I Richie Ehrlich; Mark M Davis
Journal:  Immunity       Date:  2008-11-14       Impact factor: 31.745

9.  Exploring dendritic cell based vaccines targeting survivin for the treatment of head and neck cancer patients.

Authors:  Annelies W Turksma; Hetty J Bontkes; Janneke J Ruizendaal; Kirsten B J Scholten; Johanneke Akershoek; Shakila Rampersad; Laura M Moesbergen; Saskia A G M Cillessen; Saskia J A M Santegoets; Tanja D de Gruijl; C René Leemans; Chris J L M Meijer; Erik Hooijberg
Journal:  J Transl Med       Date:  2013-06-20       Impact factor: 5.531

10.  Macroautophagy substrates are loaded onto MHC class II of medullary thymic epithelial cells for central tolerance.

Authors:  Martin Aichinger; Chunyan Wu; Jelena Nedjic; Ludger Klein
Journal:  J Exp Med       Date:  2013-02-04       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.